Psoriasis: open trials in China

49 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07351448
Research on the Extraction of Tongue and Facial Diagnosis Features of Psoriasis Vulgaris in Traditional Chinese Medicine and Its Correlation With Laboratory Indicators
Research · Shanghai Yueyang Integrated Medicine Hospital
Shanghai Yueyang Integrated Medicine Hospital, Shanghai
Registry updated 2026-01-20
NCT07251998
Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis
Trial Treatment · Phase 2 · Beijing InnoCare Pharma Tech Co., Ltd.
Shanghai Dermatology Hospital, Shanghai
Registry updated 2025-12-31
NCT07194200
Safety and Efficacy of Lactobacillus Plantarum for Psoriasis: A Randomized Double-Blind Placebo-Controlled Trial
Trial Treatment · Phase 2 · Shenzhen People's Hospital
Shenzhen People's Hospital, Shenzhen
Registry updated 2025-12-24
NCT07265284
A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Trial Treatment · Phase 3 · Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Beijing Children's Hospital Affiliated to Capital Medical University, Beijing
Registry updated 2025-12-22
NCT07130604
Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis
Trial Treatment · Phase 3 · InventisBio Co., Ltd
Peking University People's Hospital, Beijing
Registry updated 2025-12-09
NCT06376474
To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage
Trial Treatment · Phase 1 · Ganzhou Hemay Pharmaceutical Co., Ltd
Union Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan
Registry updated 2025-12-04
NCT07234591
A Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis
Trial Treatment · Usynova Pharmaceuticals Ltd.
Shanghai Skin Disease Hospital, Shanghai
Registry updated 2025-11-18
NCT07038720
A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis
Trial Treatment · Phase 1 · Usynova Pharmaceuticals Ltd.
Hangzhou First People's Hospital, Hangzhou
Registry updated 2025-11-17
NCT07150988
A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis
Trial Treatment · Phase 2 · Haisco Pharmaceutical Group Co., Ltd.
Hangzhou First People's Hospital, Hangzhou
Registry updated 2025-09-02
NCT07102888
A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis
Trial Treatment · Phase 2 · Jiangsu HengRui Medicine Co., Ltd.
Beijing Children's Hospital, Capital Medical University, Beijing
Registry updated 2025-08-05
NCT07033234
Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118
Trial Treatment · Phase 1 · Jiangsu Hansoh Pharmaceutical Co., Ltd.
Affiliated Hangzhou First People's Hospital, Hangzhou
Registry updated 2025-06-24
NCT06987292
A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)
Research · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Department of Dermatology, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing
Registry updated 2025-05-23
NCT06982196
Sulodexide in Controlling the Recurrence of Psoriasis
Trial Treatment · Phase 3 · Xijing Hospital
xjjing Hospital, Xi'an
Registry updated 2025-05-21
NCT06696417
Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis
Research · First Hospital of China Medical University
The First Hospital of China Medical University, Shenyang
Registry updated 2025-05-14
NCT06926582
A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis
Trial Treatment · Phase 2 · Hansoh BioMedical R&D Company
Shanghai Dermatology Hospital, Shanghai
Registry updated 2025-04-13
NCT06912165
A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis
Trial Treatment · Phase 2 · Zhejiang Wenda Pharma Technology LTD.
Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences, Peking Union Medical College, Nanjing
Registry updated 2025-04-11
NCT06231381
Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)
Trial Treatment · Phase 2 · Shanghai Huaota Biopharmaceutical Co., Ltd.
Peking University People's Hospital (PKUPH), Beijing · Shanghai Huaota Biopharmaceutical Co., Ltd, Shanghai
Registry updated 2025-03-19
NCT06833307
The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque Psoriasis
Trial Treatment · Phase 3 · Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Capital Medical University Affiliated Children's Hospital, Beijing · Shanghai Huashan Hospital, Shanghai
Registry updated 2025-02-18
NCT06802848
Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)
Research · Chongqing Genrix Biopharmaceutical Co., Ltd
Xiangya Hospital of Central South University, Hunan
Registry updated 2025-01-31
NCT06779097
Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis
Trial Treatment · Phase 4 · Suzhou Suncadia Biopharmaceuticals Co., Ltd.
China-Japan Friendship Hospital, Beijing
Registry updated 2025-01-16
NCT06766552
A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
Research · Second Affiliated Hospital, Zhejiang University, School of Medicine
The Second Affiliated Hospital of Zhejiang University, Hangzhou
Registry updated 2025-01-09
NCT06730334
Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)
Research · Nanjing Medical University
Jiangsu Province Hospital, Nanjing · Department of Rheumatology and Immunology, Jiangsu Province Hospital, Nanjing
Registry updated 2024-12-20
NCT05503875
Immunoclassification of Psoriasis: a Strategy for Precision Medicine
Trial Treatment · Second Affiliated Hospital, Zhejiang University, School of Medicine
2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou
Registry updated 2024-01-12
NCT04465838
Chinese Psoriasis Real World Evidence Research
Research · Second Affiliated Hospital, Zhejiang University, School of Medicine
Beijing Children's Hospital Affiliated to Capital Medical University, Beijing · The First Affiliated Hospital of Chongqing Medical University, Chongqing · The First Affiliated Hospital of Fujian Medical University, Fujian · General Hospital of Lanzhou Military Region, Gansu · Sun Yat-sen Memorial Hospital, Guangdong · The Peoples' Hospital of Guangxi Zhuang Autonomous Region, Guangxi · The Affiliated Hospital of Guizhou Medical University, Guizhou · The Fifth People's Hospital of Hainan Province, Hainan · Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou · The First Hospital of Hebei Medical University, Hebei · the Second Affiliated Hospital of Harbin Medical Unviersity, Heilongjiang · Henan Provincial Peoples Hospital, Henan · The Affiliated Hospital of Inner Mongolia Medical University, Hohhot · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei · Xiangya Hospital Central South University, Hunan · The Second Affiliated Hospital of Nanchang University, Jiangxi · Yanbian University Hospital, Jilin City · Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing · Xining First Hospital, Qinghai · Shandong Provincial Hospital for Skin Diseases, Shandong · Shanghai Dermatology Hospital, Shanghai · Taiyuan Central Hospital, Shanxi · the Second Affiliated Hospital of Xi'an Jiaotong University, Shanxi · The First Hospital of China Medical University, Shenyang · Sichuan Provincial People's Hospital, Sichuan · Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin · First Affiliated Hospital, School of Medicine, Shihezi University, Xinjiang · General Hospital of Ningxia Medical University, Yinchuan · The second affiliated hospital of Kunming medical university, Yunnan
Registry updated 2024-01-05

All Psoriasis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error